A platform for minimally invasive peripheral lung biopsy advancing robotics in thoracic oncology
Innovation with intention to transform lung cancer care
In lung cancer, time to intervention is critical. Ion enables clinical confidence to get early answers and accelerates program impact. Ion delivers meaningful innovation so clinicians can continue to advance care for their lung cancer patients.
We built Ion on the belief that collecting lung tissue samples for biopsy could be safe and simple, even when lung nodules are small and located in the periphery. Ion’s ultrathin, ultramaneuverable catheter allows clinicians to reach small lesions in all 18 segments of the lung with more reach, precision, and stability.
Reimagining the lung cancer patient pathway
Patients who learn they have a suspicious lung nodule shouldn’t have to wait to find out if they have lung cancer. Instead, they should be able to get definitive answers without delay. Today, many patients are told to return months later for a follow-up CT scan to see if the nodule has grown.2 Patients may also require multiple biopsies prior to a lung cancer diagnosis, which can add months to a patient’s journey to care.3
A chief goal in designing Ion was to help shorten the patient journey by making it possible to biopsy small, difficult-to-reach nodules in the peripheral lung, where more than 70% of cancerous lung nodules may be located.4 Since Ion’s introduction in 2019, we’ve made progress in achieving that goal.
Visit our Research and Outcomes page to learn what recent studies say about how Ion is helping physicians get early answers for their patients.